Compare · head to head
Apogee Therapeutics vs Vir Biotechnology
Apogee Therapeutics ranks higher overall — 360 rank 58 vs 56.
Apogee Therapeutics leads on Quality (50 vs 40). Vir Biotechnology leads on Growth (63 vs 57) and Safety (54 vs 36). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Medium |
| ISIN | US03770N1019 | US92764N1028 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 58 | 56 |
| Value | NR | 37 |
| Quality | 50 | 40 |
| Growth | 57 | 63 |
| Safety | 36 | 54 |
| Sentiment | 66 | 62 |
| Quality details | ||
| Profitability | 49 | 33 |
| Cash Truth | NR | 46 |
Apogee Therapeutics vs Connect Biopharma HoldingsApogee Therapeutics vs Protagonist TherapeuticsApogee Therapeutics vs ImageneBioAdd a third stock →
Full analyses: Apogee Therapeutics · Vir Biotechnology
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100